176 related articles for article (PubMed ID: 9600682)
21. Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis.
Yeh JH; Chiu HC
J Neurol; 2000 Jul; 247(7):510-3. PubMed ID: 10993491
[TBL] [Abstract][Full Text] [Related]
22. [Apheresis therapy in Guillain-Barré syndrome].
Nagayama H; Katayama Y
Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
[TBL] [Abstract][Full Text] [Related]
23. Anti-ganglioside antibody and neuropathy: review of our research.
Yuki N
J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
[TBL] [Abstract][Full Text] [Related]
24. The effect of immunoadsorption with the Immusorba TR-350 column on coagulation compared to plasma exchange.
Koessler J; Kobsar A; Kuhn S; Koessler A; Yilmaz P; Weinig E; Putz E; Boeck M; Klinker E
Vox Sang; 2015 Jan; 108(1):46-51. PubMed ID: 25131310
[TBL] [Abstract][Full Text] [Related]
25. Lessons learned from immunoadsorption for hyperviscosity in IgM multiple myeloma-A case report.
Gauckler P; Leierer J; Kocher F; Feistritzer C; Willenbacher W; Gunsilius E; Wolf D; Neuwirt H; Mayer G; Kronbichler A
J Clin Apher; 2020 Jun; 35(3):227-230. PubMed ID: 32142176
[TBL] [Abstract][Full Text] [Related]
26. Removal Characteristics of Immunoadsorption With the Immusorba TR-350 Column Using Conventional and Selective Plasma Separators.
Ohkubo A; Okado T; Miyamoto S; Goto K; Yamamoto M; Maeda T; Itagaki A; Seshima H; Kurashima N; Sohara E; Uchida S; Rai T
Ther Apher Dial; 2016 Aug; 20(4):360-7. PubMed ID: 27523076
[TBL] [Abstract][Full Text] [Related]
27. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
Pták J
Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
[TBL] [Abstract][Full Text] [Related]
28. [Double filtration and immunoadsorption plasmapheresis in Guillain-Barré syndrome].
Kuwabara S; Nakajima M; Moroo I; Hirayama K
Rinsho Shinkeigaku; 1996 Feb; 36(2):289-92. PubMed ID: 8752682
[TBL] [Abstract][Full Text] [Related]
29. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
30. Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.
Moranne O; Ion IM; Cezar R; Messikh Z; Prelipcean C; Chkair S; Thouvenot E; Tran TA; Corbeau P; Chevallier T
BMC Neurol; 2022 Aug; 22(1):293. PubMed ID: 35931957
[TBL] [Abstract][Full Text] [Related]
31. [Plasmapheresis in patients with myasthenia gravis].
Konishi T
Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
[TBL] [Abstract][Full Text] [Related]
32. Double filtration plasmapheresis - 10-year pediatric experience as an alternative to plasma exchange.
Maxted AP; Connell R; Hussain F
Transfus Apher Sci; 2020 Dec; 59(6):102928. PubMed ID: 32919882
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
[TBL] [Abstract][Full Text] [Related]
34. Removal kinetics of antibodies against glutamic acid decarboxylase by various plasmapheresis modalities in the treatment of neurological disorders.
Ohkubo A; Okado T; Kurashima N; Maeda T; Miyamoto S; Nakamura A; Seshima H; Iimori S; Sohara E; Uchida S; Rai T
Ther Apher Dial; 2014 Jun; 18(3):231-7. PubMed ID: 24965288
[TBL] [Abstract][Full Text] [Related]
35. Selective plasma exchange.
Ohkubo A; Okado T
Transfus Apher Sci; 2017 Oct; 56(5):657-660. PubMed ID: 28939369
[TBL] [Abstract][Full Text] [Related]
36. [Comparative study of the efficacy of plasma exchange, immunoadsorption plasmapheresis and corticosteroid administration in the treatment of Guillain-Barré syndrome].
Yamazaki M; Koh CS; Hanyu N; Sakai T; Inoue A; Yanagisawa N
Arerugi; 1995 Apr; 44(4):498-502. PubMed ID: 7598643
[TBL] [Abstract][Full Text] [Related]
37. Apheresis and selective adsorption plus immunoglobulin treatment in Guillain-Barré syndrome.
Haupt WF; Birkmann C; van der Ven C; Pawlik G
Ther Apher; 2000 Jun; 4(3):198-200. PubMed ID: 10910019
[TBL] [Abstract][Full Text] [Related]
38. Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA Antibodies.
Maillard N; Absi L; Claisse G; Masson I; Alamartine E; Mariat C
Blood Purif; 2015; 40(2):167-72. PubMed ID: 26278703
[TBL] [Abstract][Full Text] [Related]
39. Double filtration plasmapheresis: Review of current clinical applications.
Hirano R; Namazuda K; Hirata N
Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
[TBL] [Abstract][Full Text] [Related]
40. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage.
Funauchi M; Ikoma S; Imada A; Kanamaru A
J Clin Lab Immunol; 1997; 49(2):47-57. PubMed ID: 9819673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
